| For: | Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol 2016; 22(3): 1260-1278 [PMID: 26811663 DOI: 10.3748/wjg.v22.i3.1260] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1260.htm |
| Number | Citing Articles |
| 1 |
Subrahmanyam Vangala, Uday Saxena, C. Satish Chandran. Microfluidics and Multi Organs on Chip. 2022; doi: 10.1007/978-981-19-1379-2_29
|
| 2 |
Zhicheng Gu, Mingzhenglong Deng, Qinggen Luo, Shuxian Lin, Junhui Yu, Cunjiang Li, Xingyu Wang, Lei Chen, Ting Liu, Yan Li, Bin He. Harnessing HDAC-targeted oleanolic acid derivatives for combined anti-cancer and hepatoprotective effects. International Journal of Biological Macromolecules 2025; 297 doi: 10.1016/j.ijbiomac.2025.139761
|
| 3 |
Juveriya Farooq, M.M. Sana, P.M. Chetana, Mansour Almuqbil, Nagapati Prabhakar Bhat, Rokeya Sultana, UmaimaFarheen Khaiser, Syed Mohammed Basheeruddin Asdaq, Mutlaq Eidhah M. Almalki, Amro Mohammed sawadi Khormi, Salem Ahmad Albraiki, Moneer E. Almadani. Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life. Saudi Pharmaceutical Journal 2023; 31(8) doi: 10.1016/j.jsps.2023.06.001
|
| 4 |
Lianne J. Stevens, Joanne M. Donkers, Jeroen Dubbeld, Wouter H. J. Vaes, Catherijne A. J. Knibbe, Ian P. J. Alwayn, Evita van de Steeg.
Towards human
ex vivo
organ perfusion models to elucidate drug pharmacokinetics in health and disease
. Drug Metabolism Reviews 2020; 52(3) doi: 10.1080/03602532.2020.1772280
|
| 5 |
Bo Jiang, Jiaxin Wei, Xiaochen Liu, Longlin He, Taotao Hou, Bin Niu. Safety profile of artemether: Analysis based on 15-year data retrived from FDA adverse event reporting system (FAERS). Asian Pacific Journal of Tropical Medicine 2026; 19(1) doi: 10.4103/apjtm.apjtm_95_25
|
| 6 |
Maddi Srinivas. Cytochrome P450 Enzymes, Drug Transporters and their Role in Pharmacokinetic Drug-Drug Interactions of Xenobiotics: A Comprehensive Review. Open Journal of Chemistry 2017; doi: 10.17352/ojc.000006
|
| 7 |
Yueqing Pan, Zhuan Yang, Minlong Wei, Yulin Gan, Menghua Liu, Wei Zou. Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney. European Journal of Drug Metabolism and Pharmacokinetics 2025; 50(1) doi: 10.1007/s13318-024-00923-2
|
| 8 |
Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology 2024; 90(4) doi: 10.1111/bcp.15990
|
| 9 |
Beshoy Armanios, Jing Jin, Xiao-bo Zhong. Drug Metabolism in Diseases. 2026; doi: 10.1016/B978-0-443-29289-7.00001-1
|
| 10 |
Venkatesh Pilla Reddy, Khanh Bui, Graeme Scarfe, Diansong Zhou, Maria Learoyd. Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations. Clinical Pharmacology & Therapeutics 2019; 105(1) doi: 10.1002/cpt.1103
|
| 11 |
Samuel Cyr, Lydia Abdelaziz, Anthony Minichiello, Maxime Bouvier, Orielle Djona, Céline Fiset, Rafik Tadros, Sylvie Levesque, Charline Daval, Viviane Lavigne, Paul Khairy, Stanley Nattel, Judith Brouillette. Impact of antidepressant and antipsychotic use in the occurence of torsades de pointes arrhythmia: a case-control study. General Hospital Psychiatry 2025; 94 doi: 10.1016/j.genhosppsych.2025.02.002
|
| 12 |
Daniela Gabbia, Arianna Dalla Pozza, Laura Albertoni, Roberta Lazzari, Giorgia Zigiotto, Maria Carrara, Vincenzo Baldo, Tatjana Baldovin, Annarosa Floreani, Sara De Martin. Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis. World Journal of Gastroenterology 2017; 23(42): 7519-7530 doi: 10.3748/wjg.v23.i42.7519
|
| 13 |
Nokwanda N. Ngcobo. Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review. Clinical Pharmacokinetics 2025; doi: 10.1007/s40262-024-01466-0
|
| 14 |
Arnab Bhattacharjee, Ankur Kumar, Probir Kumar Ojha, Supratik Kar. Artificial intelligence to predict inhibitors of drug-metabolizing enzymes and transporters for safer drug design. Expert Opinion on Drug Discovery 2025; 20(5) doi: 10.1080/17460441.2025.2491669
|
| 15 |
Flavia Storelli, Caroline Samer, Jean-Luc Reny, Jules Desmeules, Youssef Daali. Complex Drug–Drug–Gene–Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives. Clinical Pharmacokinetics 2018; 57(10) doi: 10.1007/s40262-018-0650-9
|
| 16 |
Wubshet Tesfaye, Ronald L. Castelino, Monica Zolezzi, Fatima Small. Principles and Practice of Pharmacovigilance and Drug Safety. 2024; doi: 10.1007/978-3-031-51089-2_22
|
| 17 |
Ying‐Jung Wu, Ching‐Hui Huang, Tusty‐Jiuan Hsieh, Wei‐Lung Tseng, Chi‐Yu Lu. Identification of significant protein markers by mass spectrometry after co‐treatment of cells with different drugs: An in vitro survey platform. Rapid Communications in Mass Spectrometry 2020; 34(S1) doi: 10.1002/rcm.8582
|
| 18 |
Ira M. Jacobson, Fred Poordad, Roberto Firpi-Morell, Gregory T. Everson, Elizabeth C. Verna, Sanhita Bhanja, Peggy Hwang, Luzelena Caro, Michael Robertson, Edgar D. Charles, Heather Platt. Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study. Clinical and Translational Gastroenterology 2019; 10(4) doi: 10.14309/ctg.0000000000000007
|
| 19 |
Nicolas Cottura, Hannah Kinvig, Sandra Grañana‐Castillo, Adam Wood, Marco Siccardi. Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives. The Journal of Clinical Pharmacology 2022; 62(7) doi: 10.1002/jcph.2025
|
| 20 |
Tao Wang, Fan Zhang, Xiaotong Wang, Xizhi Li, Hongwei Ling, Dongmei Lv, Xiaoxing Yin, Qian Lu. Predictive factors associated with glycaemic response to exenatide in Chinese patients with type 2 diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics 2020; 45(5) doi: 10.1111/jcpt.13134
|
| 21 |
Lakshmi Viswanathan, Eric Bachman, Simon Tian, Neil Ahluwalia, Yaohua Zhang, Harold S. Bernstein, Paul Panorchan. Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment. European Journal of Drug Metabolism and Pharmacokinetics 2022; 47(6) doi: 10.1007/s13318-022-00791-8
|
| 22 |
Yogendra Pal, Pran Kishore Deb, Shantanu Bandopadhyay, Nabamita Bandyopadhyay, Rakesh K. Tekade. Dosage Form Design Considerations. 2018; doi: 10.1016/B978-0-12-814423-7.00003-4
|
| 23 |
Sanjita Paudel, Hyoje Jo, Taeho Lee, Sangkyu Lee. Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes. Biopharmaceutics & Drug Disposition 2023; 44(5) doi: 10.1002/bdd.2370
|
| 24 |
Ivana Mikolašević, Tajana Filipec Kanižaj, Viktor Domislović, Duško Kardum. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; doi: 10.1007/978-3-031-69800-2_22
|
| 25 |
Wonsuk Shin, Dong Hyeon Lee, Minseok Hong, Min-Kyoung Kim, Hyounggyoon Yoo, Yil-Seob Lee, Sra Jung. Increased Anticholinergic Agent Use With Co-prescription of CYP2D6-Inhibiting SSRIs and Risperidone, but not Aripiprazole: A Nationwide Cohort Study. Schizophrenia Bulletin 2025; doi: 10.1093/schbul/sbaf189
|
| 26 |
Wei Yin, Pranab Mitra, Veronique Copalu, Thomas C. Marbury, Juan Carlos Rondon, Eric J. Lawitz, Valerie Lloyd, Mike Baratta, Mahnaz Asgharnejad, Tom Hui, Yasir Khan. Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function. Pharmacology Research & Perspectives 2024; 12(4) doi: 10.1002/prp2.1213
|
| 27 |
Kevin N. Woodward. Regulatory Toxicology in the European Union. 2018; doi: 10.1039/9781782622222-00243
|
| 28 |
Takumi Kawanishi, Hiroshi Arakawa, Yusuke Masuo, Noritaka Nakamichi, Yukio Kato. Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib. Journal of Pharmaceutical Sciences 2019; 108(9) doi: 10.1016/j.xphs.2019.05.017
|
| 29 |
Eyad Gadour, Ahmed Kotb. Systematic Review of Antifungal-Induced Acute Liver Failure. Cureus 2021; doi: 10.7759/cureus.18940
|
| 30 |
Dong Dong, Hua Sun, Zhufeng Wu, Baojian Wu, Yunxia Xue, Zhijie Li. A validated ultra-performance liquid chromatography-tandem mass spectrometry method to identify the pharmacokinetics of SR8278 in normal and streptozotocin-induced diabetic rats. Journal of Chromatography B 2016; 1020 doi: 10.1016/j.jchromb.2016.03.033
|
| 31 |
Carolina Jiménez-González, Paula Iruzubieta, Marta Alonso-Peña, Lorena Cayón, Javier Crespo. Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD). Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1884657
|
| 32 |
David M. Hensler, Deepika P. McConnell, Kimberly E. Levasseur-Franklin, Kasey M. Greathouse. Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the Literature. Journal of Pharmacy Practice 2018; 31(6) doi: 10.1177/0897190017743130
|
| 33 |
Eman El-Khateeb, Brahim Achour, Zubida M. Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan. Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment. Molecular Pharmaceutics 2021; 18(9) doi: 10.1021/acs.molpharmaceut.1c00462
|
| 34 |
Engy A. Mogahed, Noha Adel Yassin, Ehab A. Atef, Basma A. Abd El Zaher, Rania Ramzi, Merna Adel Aziz, Haytham Ghita. Drug–drug interactions in hospitalized children with liver diseases: incidence, severity, and risk factors. Egyptian Pediatric Association Gazette 2026; 74(1) doi: 10.1186/s43054-026-00566-9
|
| 35 |
Liwei Yang, Aipeng Ju, Yawen Huang, Huibin Jiang, Jiaming Ye, Wen Qi, Liting Zhou. Tributyl phosphate as a type of environmental endocrine disruptor associated with liver fibrosis: insights from NHANES and in vitro validation. Frontiers in Toxicology 2025; 7 doi: 10.3389/ftox.2025.1623830
|
| 36 |
Avishek Mandal, Sanmoy Karmakar, Mithun Bhowmick, Sweet Naskar, Ankita Sadhukhan, Arnab Sarkar, Pratibha Bhowmick, Jiong Yu. Progression of Malaria in the Human Body, Its Effects on the Liver and Its Various Aspects. Advanced Gut & Microbiome Research 2026; 2026(1) doi: 10.1155/agm3/5375356
|
| 37 |
Andrew H. Talal, Charles S. Venuto, Islam Younis. Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment. Clinical Pharmacology in Drug Development 2017; 6(2) doi: 10.1002/cpdd.336
|
| 38 |
Jongkwon Park, Yun Jung Heo, Soonjo Kwon. Interaction Between Hepatocytes and Proximal Tubular Epithelial Cells in Hypoxia-induced Lipotoxicity. Biotechnology and Bioprocess Engineering 2022; 27(1) doi: 10.1007/s12257-021-0137-7
|
| 39 |
Luiza Blambila, Poliana Sabei, Vitória Gomes Raulino, Marcos Edgar Herkenhoff. Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1773677
|
| 40 |
Kathryn M. Musgrave, Kieron Power, Mike Laffan, James S. O’Donnell, Jecko Thachil, Anthony Maraveyas. Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement. Critical Reviews in Oncology/Hematology 2022; 171 doi: 10.1016/j.critrevonc.2022.103599
|
| 41 |
Kazuya Maeda, Akihiro Hisaka, Kiyomi Ito, Yoshiyuki Ohno, Akihiro Ishiguro, Reiko Sato, Naomi Nagai. Classification of drugs for evaluating drug interaction in drug development and clinical management. Drug Metabolism and Pharmacokinetics 2021; 41 doi: 10.1016/j.dmpk.2021.100414
|
| 42 |
Sarah Kazemeini, Ryan Shih, Sunny Zhang, Raphael Cohen, Nathaniel LaBarre, Moonis Ghani, George Tsao. Individualizing Perioperative Analgesia: Patient-Specific Determinants of Postoperative Pain and Opioid-Related Outcomes. Medicina 2026; 62(9) doi: 10.3390/medicina62091789
|
| 43 |
Reeju Amatya, Kyoung Ah Min, Meong Cheol Shin. Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges. International Journal of Molecular Sciences 2026; 27(16) doi: 10.3390/ijms27167118
|
| 44 |
Zhenyan Yu, Xiaohan Hu, Lin Zhou, Huliang Chen, Yanchao Xing, Chunyue Han, Hui Ding, Lifeng Han, Guixiang Pan, Zhifei Fu. Studies on Chemical Characterization of Ginkgo Amillaria Oral Solution and Its Drug–Drug Interaction With Piceatannol 3′-O-β-D-Glucopyranoside for Injection. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.932646
|
| 45 |
Antonio Corona, Mary Dominguez, Serife Eti. Palliative Care in Kidney and Liver Diseases. Advances in Kidney Disease and Health 2023; 30(4) doi: 10.1053/j.akdh.2023.07.003
|
| 46 |
Rosemary T. Smith, Staci A. Gruber. Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Frontiers in Psychiatry 2023; 13 doi: 10.3389/fpsyt.2022.1055481
|
| 47 |
Russell R. Kempker, Wael A. Alghamdi, Mohammad H. Al-Shaer, Gena Burch, Charles A. Peloquin. A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment. Antimicrobial Agents and Chemotherapy 2019; 63(12) doi: 10.1128/AAC.01215-19
|
| 48 |
Carmen Kirchner, Jasmin Sibai, Elke Schwier, Dietrich Henzler, Claas Eickmeyer, Günther Winde, Thomas Köhler. Dosing of Antimycotic Treatment in Sepsis–Induced Liver Dysfunction by Functional Liver Testing with LiMAx®. Case Reports in Critical Care 2019; 2019 doi: 10.1155/2019/5362514
|
| 49 |
Zubida M. Al‐Majdoub, Martyn Howard, Brahim Achour, Jill Barber, Naved Alizai, Amin Rostami‐Hodjegan. Unveiling Hepatic Protein Alterations in Neonatal and Infant Biliary Atresia. Clinical Pharmacology & Therapeutics 2026; 119(6) doi: 10.1002/cpt.70244
|
| 50 |
Mason McComb, Panli Cardona, Caitlin Sampson, Jessica Purkis, Christopher A. James, Brett Houk. Clinical Impact of Hepatic Impairment on the Pharmacokinetics of Sotorasib and Its Major Metabolites: Implications for Dose Adjustment. The Journal of Clinical Pharmacology 2025; 65(12) doi: 10.1002/jcph.70095
|
| 51 |
Akifumi Kurata, Takafumi Yoshida, Megumi Inoue, Tomoko Ishizuka, Takafumi Nakatsu, Takako Shimizu, Manabu Kato, Yasuhiro Nishikawa, Hitoshi Ishizuka. Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment. Advances in Therapy 2020; 37(1) doi: 10.1007/s12325-019-01121-2
|
| 52 |
Kehua Zhou, Christos Fountzilas. Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma. Cancers 2019; 11(6) doi: 10.3390/cancers11060861
|
| 53 |
Sivacharan Kollipara, Tausif Ahmed, Sivadasu Praveen. Physiologically based pharmacokinetic modeling (PBPK) to predict drug-drug interactions for encorafenib. Part II. Prospective predictions in hepatic and renal impaired populations with clinical inhibitors and inducers. Xenobiotica 2023; 53(5) doi: 10.1080/00498254.2023.2246153
|
| 54 |
EMRE KARA, Kamer Tecen-Yücel, Nesligül Özdemir, Ahmet Çağkan İnkaya, Aygin Bayraktar-Ekincioğlu, Kutay Demirkan, Serhat Ünal. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi. STED / Sürekli Tıp Eğitimi Dergisi 2019; doi: 10.17942/sted.599700
|
| 55 |
Martyn Howard, Jill Barber, Naved Alizai, Amin Rostami-Hodjegan. Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12) doi: 10.1080/17425255.2018.1546288
|
| 56 |
Josefina Gómez-Garduño, Renato León-Rodríguez, Radamés Alemón-Medina, Beatriz E. Pérez-Guillé, Rosa E. Soriano-Rosales, Ailema González-Ortiz, Juan L. Chávez-Pacheco, Edelmira Solorio-López, Paola Fernandez-Pérez, Liliana Rivera-Espinosa. Phytochemicals That Interfere With Drug Metabolism and Transport, Modifying Plasma Concentration in Humans and Animals. Dose-Response 2022; 20(3) doi: 10.1177/15593258221120485
|
| 57 |
Sorina Hîncu, Miruna-Maria Apetroaei, Gabriela Ștefan, Anca Ionela Fâcă, Andreea Letiția Arsene, Beatrice Mahler, Doina Drăgănescu, Adriana-Elena Tăerel, Emilia Stancu, Lucian Hîncu, Andreea Zamfirescu, Denisa Ioana Udeanu. Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091137
|
| 58 |
Zachary McCalla, Xinwen Wang. Mass spectrometry-based absolute quantitative proteomics of drug-metabolizing enzymes in human liver. Pharmacology & Therapeutics 2025; 275 doi: 10.1016/j.pharmthera.2025.108929
|
| 59 |
Khalid Alshaghdali, Talal Alharazi, Raja Rezgui, Tolgahan Acar, Raed Fahad Aljerwan, Ahmed Altayyar, Munazzah Tasleem, Mohd Saeed, Dharmendra Kumar Yadav, Amir Saeed. Identification and evaluation of putative type 2 diabetes mellitus inhibitors derived from Cichorium intybus. Journal of Molecular Structure 2024; 1306 doi: 10.1016/j.molstruc.2024.137629
|
| 60 |
Yuki Tabata. Metabolic Diversion from Geranylgeranoic Acid to 2,3-Dihydrogeranylgeranoic Acid in Hepatic Tumor Surveillance. Livers 2026; 6(5) doi: 10.3390/livers6050082
|
| 61 |
Eman El‐Khateeb, Adam S. Darwich, Brahim Achour, Varinder Athwal, Amin Rostami‐Hodjegan. Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment. Alimentary Pharmacology & Therapeutics 2021; 54(4) doi: 10.1111/apt.16489
|
| 62 |
Chia Siang Kow, Kaeshaelya Thiruchelvam, Dinesh Sangarran Ramachandram. The Palgrave Encyclopedia of Disability. 2026; doi: 10.1007/978-3-032-11375-7_439
|
| 63 |
Kelly M. Mahar, Bonnie C. Shaddinger, Bandi Ramanjineyulu, Susan Andrews, Stephen Caltabiano, Alistair C. Lindsay, Alexander R. Cobitz. Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function. Clinical Pharmacology in Drug Development 2022; 11(5) doi: 10.1002/cpdd.1090
|
| 64 |
Marija Jovanović, Milena Kovačević, Sandra Vezmar-Kovačević, Ivan Palibrk, Jasna Bjelanović, Branislava Miljković, Katarina Vučićević. Lidocaine clearance as pharmacokinetic parameter of metabolic hepatic activity in patients with impaired liver. Journal of Medical Biochemistry 2023; 42(2) doi: 10.5937/jomb0-38952
|
| 65 |
Michael D. Wiese, Ashley S. Meakin, Tamara J. Varcoe, Jack R.T. Darby, Ousseynou Sarr, Patti Kiser, Emma L. Bradshaw, Timothy R.H. Regnault, Janna L. Morrison. Hepatic cytochrome P450 function is reduced by life-long Western diet consumption in guinea pig independent of birth weight. Life Sciences 2021; 287 doi: 10.1016/j.lfs.2021.120133
|
| 66 |
Xiao-nan Gao, Xu-yang Nie, Jing-lin Gao, Tian-fang Heng, Yu-qi Zhang, Li Hua, Ya-qi Sun, Zhang-ying Feng, Ming-xia Wang, Li Jia. Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction. Drug Design, Development and Therapy 2022; doi: 10.2147/DDDT.S371596
|
| 67 |
Nagaraj M. Kulkarni, Sandeep Malampati, Mahamad Yunnus A. Mahat, S. Chandrasekaran, J. Raghul, Ansar Ali Khan, Uma Maheswari Krishnan, Shridhar Narayanan. Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease. Drug Metabolism and Personalized Therapy 2016; 31(3) doi: 10.1515/dmpt-2016-0008
|
| 68 |
Nikolaos Spernovasilis, Diamantis P. Kofteridis. Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi 2018; 4(4) doi: 10.3390/jof4040133
|
| 69 |
Chia Siang Kow, Kaeshaelya Thiruchelvam, Dinesh Sangarran Ramachandram. The Palgrave Encyclopedia of Disability. 2025; doi: 10.1007/978-3-031-40858-8_439-1
|
| 70 |
Heidemarie Kletzl, Hassan Ajmi, Izabela Antys, Katja Heinig, Birgit Jaber, Thomas C. Marbury, Annie Young, Andreas Günther. Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam. British Journal of Clinical Pharmacology 2022; 88(8) doi: 10.1111/bcp.15319
|
| 71 |
Marina Mudrovčić, Lucija Virović Jukić, Doris Ogresta, Ivica Grgurević. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; doi: 10.1007/978-3-031-69800-2_30
|
| 72 |
Arwa R. Althaher, Yazun Jarrar, Mahmood Ayad Al-Ibadah, Ruba Balasmeh, Qais Jarrar, Dina Abulebdah. Effects of Calamintha incana (Sm.) Helder Ethanolic Extract on the mRNA
Expression of Drug-metabolizing cyp450s in the Mouse Livers. MicroRNA 2024; 13(1) doi: 10.2174/0122115366268781231205103752
|
| 73 |
Daniela Sarria-Gómez, Cristhian Camilo Martínez Torres, Diana Estrada-Bermúdez, Liliana Saavedra. Early Palliative Care Integration in End-Stage Liver Disease: A Narrative Review of Clinical Strategies for Symptom Control and Quality of Life. Journal of Pain & Palliative Care Pharmacotherapy 2026; 40(2) doi: 10.1080/15360288.2026.2613837
|
| 74 |
William Cruz, Huang Huang, Brian Barber, Elisa Pasini, Lili Ding, Gang Zheng, Juan Chen, Mamatha Bhat. Lipoprotein‐Like Nanoparticle Carrying Small Interfering RNA Against Spalt‐Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor Burden. Hepatology Communications 2020; 4(5) doi: 10.1002/hep4.1493
|
| 75 |
James A. Akingbasote, Sandra K. Szlapinski, Elora Hilmas, Kyle Weston, Yelena Wu, Alexandra Burton. Basics and Clinical Applications of Drug Disposition in Special Populations. 2025; doi: 10.1002/9781394251315.ch4
|
| 76 |
Anna Papinska, Lakshmi Viswanathan, Qiang Lu, Farida Abane, Charles Psoinos, Rodrigo Ruiz-Soto. Pharmacokinetics and Safety of Ripretinib in Participants with Hepatic Impairment: A Phase 1 Study. Advances in Therapy 2025; 42(9) doi: 10.1007/s12325-025-03307-3
|
| 77 |
Nicholas E. Heger. Pharmacokinetics and Therapeutic Drug Monitoring in Liver and Kidney Disease. Clinics in Laboratory Medicine 2026; doi: 10.1016/j.cll.2026.07.002
|
| 78 |
Jean-Luc Szpakowski, Lue-Yen Tucker, David M Baer, Mary Pat Pauly. Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study. Canadian Liver Journal 2022; 5(1) doi: 10.3138/canlivj-2021-0018
|
| 79 |
Qusai Y Al-Share, Aseel Y Tahrawi, Dyala M Khasawneh, Aya W Alshare, Shrouq A Alkhasawneh. Retrospective evaluation of medication appropriateness in older adults with hepatic cirrhosis. Science Progress 2025; 108(2) doi: 10.1177/00368504251330037
|
| 80 |
Sheng Huang, Renhan Dong, Gaojie Xu, Jin Liu, Xiaofang Gao, Siqi Yu, Pengfan Qie, Gang Gou, Min Hu, Yu Wang, Jian Peng, Bing Guang, Ying Xu, Tai Yang. Synthesis, Characterization, and In Vivo Evaluation
of Desmethyl Anethole Trithione Phosphate Prodrug for Ameliorating
Cerebral Ischemia-Reperfusion Injury in Rats. ACS Omega 2020; 5(9) doi: 10.1021/acsomega.9b04129
|
| 81 |
Paola Infante, Alessio Malfanti, Deborah Quaglio, Silvia Balducci, Sara De Martin, Francesca Bufalieri, Francesca Mastrotto, Irene Basili, Mariangela Garofalo, Ludovica Lospinoso Severini, Mattia Mori, Isabella Manni, Marta Moretti, Carmine Nicoletti, Giulia Piaggio, Paolo Caliceti, Bruno Botta, Francesca Ghirga, Stefano Salmaso, Lucia Di Marcotullio. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. Cancer Letters 2021; 499 doi: 10.1016/j.canlet.2020.11.028
|
| 82 |
Jingheng Wu, Miaomiao Li, Shuai Wang. Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment. Clinical Pharmacokinetics 2026; 65(9) doi: 10.1007/s40262-026-01691-9
|
| 83 |
Marina Pinheiro Lima Rosa, André Tadeu Gotardo, Ana Rita Oprimi Maramarque, Giselle Kindlein, Caroline Andrade Tomaszewski, Daniel Rodrigo Hillesheim, Graciane Fabiela da Silva, Lucas Sucheki Barnet, Renata Batista Rau, Tamara dos Santos Castilhos, Fabiano Barreto, Silvana Lima Górniak. The effect of breed on ivermectin residues in the edible tissues of cattle and the estimated withdrawal period. Food Additives & Contaminants: Part A 2025; 42(1) doi: 10.1080/19440049.2024.2423199
|
| 84 |
Charles S. Venuto, Andrew H. Talal. Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology. Clinical Pharmacology in Drug Development 2017; 6(2) doi: 10.1002/cpdd.311
|
| 85 |
Weihang Li, Ziyi Ding, Dong Wang, Chengfei Li, Yikai Pan, Yingjing Zhao, Hongzhe Zhao, Tianxing Lu, Rui Xu, Shilei Zhang, Bin Yuan, Yunlong Zhao, Yanjiang Yin, Yuan Gao, Jing Li, Ming Yan. Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02041-4
|
| 86 |
Moying Li, Timo Itzel, Nathally Espinosa Montagut, Thomas Falconer, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias Philip Ebert, George Hripcsak, Andreas Teufel. Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 2023; 58(12) doi: 10.1080/00365521.2023.2239974
|
| 87 |
Drug Interactions: Understanding and Preventing Adverse Effects. 2026; doi: 10.2174/9798898814328126010009
|
| 88 |
Wondim Ayenew, Getahun Asmamaw, Arebu Issa. Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies. BMC Pharmacology and Toxicology 2020; 21(1) doi: 10.1186/s40360-020-00441-2
|
| 89 |
John B. Watkins. Reference Module in Biomedical Sciences. 2024; doi: 10.1016/B978-0-323-95488-4.00014-0
|
| 90 |
Annarosa Floreani, Daniela Gabbia, Sara De Martin. Are Gender Differences Important for Autoimmune Liver Diseases?. Life 2024; 14(4) doi: 10.3390/life14040500
|
| 91 |
Elza Sundhani, Agung Endro Nugroho, Arief Nurrochmad, Ika Puspitasari, Dita Amalia Prihati, Endang Lukitaningsih. Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method. Molecules 2022; 27(20) doi: 10.3390/molecules27206901
|
| 92 |
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats. DARU Journal of Pharmaceutical Sciences 2021; 29(1) doi: 10.1007/s40199-020-00377-2
|
| 93 |
Jingyi Ma, Qiaoyu Pan, Sohan Mahto, Raghu Ramanathan, Altab Shaikh, Virender Kumar, Chalet Tan, Ram I. Mahato. Pharmacokinetics and Biodistribution of Polymeric Nanoparticles Loaded with a Small Molecule Drug in Mice with Alcoholic Liver Disease. Molecular Pharmaceutics 2025; 22(9) doi: 10.1021/acs.molpharmaceut.5c00488
|
| 94 |
Anne Caroline Alves Vieira, Fabrícia de Souza Ferreira, Januse Míllia Dantas de Araújo, Larissa Maria Gomes Dutra, Kamila Sabino Batista, Angela Maria Tribuzy de Magalhães Cordeiro, Jailane de Souza Aquino. Exploring the Potential Hepatoprotective Properties of Cactus (Cactaceae) in Liver Health and Disease Management: A Brief Review. Livers 2024; 4(2) doi: 10.3390/livers4020021
|
| 95 |
Fadi Rassam, Pim B. Olthof, Bart R. Takkenberg, Ulrich Beuers, Heinz-Josef Klümpen, Roelof J. Bennink, Krijn P. van Lienden, Marc G. Besselink, Olivier R. Busch, Joanne Verheij, Thomas M. van Gulik. Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma. HPB 2019; 21(5) doi: 10.1016/j.hpb.2018.09.021
|
| 96 |
Christian Rolfo, Nicolas Isambert, Antoine Italiano, L. Rhoda Molife, Jan H.M. Schellens, Jean‐Yves Blay, Thomas Decaens, Rebecca Kristeleit, Olivier Rosmorduc, Regina Demlova, Myung‐Ah Lee, Alain Ravaud, Katerina Kopeckova, Maria Learoyd, Wendy Bannister, Gershon Locker, Judith de Vos‐Geelen. Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment. British Journal of Clinical Pharmacology 2020; 86(9) doi: 10.1111/bcp.14283
|
| 97 |
Chun Sing Lam, Rong Hua, Phillip Lung Wai Au-Doung, Yu Kang Wu, Ho Kee Koon, Keary Rui Zhou, Herbert Ho-Fung Loong, Vincent Chi-Ho Chung, Yin Ting Cheung. Association between potential supplement–drug interactions and liver diseases in patients with cancer: A large prospective cohort study. Clinical Nutrition ESPEN 2023; 58 doi: 10.1016/j.clnesp.2023.09.919
|